InvestorsHub Logo
icon url

grandma_of_jbraika

09/01/17 6:22 AM

#5385 RE: SvsB #5383

We rate AUPH Outperform. AUPH is run by a management team with deep experience in lupus nephritis (LN) and corporate development, having executed the ALMS study for CellCept and selling Aspreva and ZymoGenetics to large pharma companies. We project a ~$1.35BN gross market opportunity for voclosporin in the US and a 75% probability of success. Promising Phase 2b results presented in 2016 and updated in early 2017 continue to derisk Voclosporin development. https://www.docdroid.net/CIKaxJ9/aurinia-pharmaceuticals-inc-leerink1.pdf

Posted by ariadinvestor - https://finance.yahoo.com/quote/Auph/community?p=Auph
icon url

grandma_of_jbraika

09/01/17 6:22 AM

#5386 RE: SvsB #5383

Promising Phase 2b results presented in 2016 and updated in early 2017 continue to DERISK Voclosporin development. AUPH is run by a management team with deep experience in lupus nephritis (LN) and corporate development, having executed the ALMS study for CellCept and selling Aspreva and ZymoGenetics to large pharma companies. We project a ~$1.35BN gross market opportunity for Voclosporin in the US and a 75% probability of success. We rate AUPH Outperform. https://www.docdroid.net/CIKaxJ9/aurinia-pharmaceuticals-inc-leerink1.pdf

Posted by ariadinvestor - https://finance.yahoo.com/quote/Auph/community?p=Auph
icon url

grandma_of_jbraika

09/01/17 6:22 AM

#5387 RE: SvsB #5383

I'm ABSOLUTELY not long. Nor am I short. But I am employed. I'm doing my job for my income. Please don't doubt my honesty. Everybody listens to me and believe my biotech research on AUPH. Don't you?

I don't set stop loss. I don't buy on margin. I don't sell. I add more when it pulls back. What can the manipulators/shorts do to my AUPH shares and my money? Ah? AUPH has very bright future. Patience is the key. I believe AUPH will be my next ARIA. I buy and hold AUPH the way I bought and held ARIA. I'm planning to add more AUPH shares now that the Glickman-Cramer interview has offered a new opportunity. I always picked/pick up the gold bags of ARIA/AUPH shares whenever the price was/is right to me. I like cheapened gold bags.

- Posted by ariadinvestor: https://finance.yahoo.com/quote/AUPH/community?p=AUPH

I like your intuitions on
picking a good investment, AND your dogged stubborness in sticking
with your convictions. It's not a guarantee that it will work
out, BUT is sure did with Ariad, and I believe it will also
have similar results here (minus the drama there).

I cannot think of another biotech where the probability
for a favorable outcome is as good as AUPH. The people
running the show are top notch, have deep experience in
both the specific science (LN related issues), and the
business acumen based on a very similar (almost
the same) medical and business situation.

While it might take two years for approval, I think we'll
see upward movement before that, after all, Aurinia does
have other indications for Voc. and potential for deal-making.


Good luck to you and fellow longs,
zzaatt/amp

PS: This two year (blinded) wait seems pretty grotesque, given the
strong results in P2 and the fact that it will cost the lives
of thousands of very desperate patients. I always had a
profound contempt for the corrupt, hide-bound bureaucracy
known as the FDA and I'm hoping for big changes under Dr.Gottlieb!
Who knows, maybe some conditional approval may be possible,
it certainly should be, if the goal is to help sick people.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=133437830